ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 271 filers reported holding ICU MED INC in Q2 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $2,235,000 | +17.3% | 10,421 | -0.0% | 0.04% | +2.7% |
Q3 2020 | $1,905,000 | -2.7% | 10,422 | -1.8% | 0.04% | -7.5% |
Q2 2020 | $1,957,000 | -5.1% | 10,617 | +3.8% | 0.04% | -16.7% |
Q1 2020 | $2,063,000 | +7.8% | 10,226 | 0.0% | 0.05% | +29.7% |
Q4 2019 | $1,913,000 | +18.9% | 10,226 | +1.5% | 0.04% | +8.8% |
Q3 2019 | $1,609,000 | -28.2% | 10,079 | +13.2% | 0.03% | -29.2% |
Q2 2019 | $2,242,000 | +6.1% | 8,900 | +0.8% | 0.05% | +9.1% |
Q1 2019 | $2,113,000 | +5.9% | 8,830 | +1.6% | 0.04% | -12.0% |
Q4 2018 | $1,996,000 | -17.1% | 8,693 | +2.1% | 0.05% | -2.0% |
Q3 2018 | $2,408,000 | +4.9% | 8,515 | +9.0% | 0.05% | -1.9% |
Q2 2018 | $2,295,000 | +19.9% | 7,815 | +3.1% | 0.05% | +15.6% |
Q1 2018 | $1,914,000 | +125.7% | 7,583 | +93.1% | 0.04% | +125.0% |
Q4 2017 | $848,000 | +20.3% | 3,927 | +3.5% | 0.02% | +17.6% |
Q3 2017 | $705,000 | +10.2% | 3,795 | +2.3% | 0.02% | +6.2% |
Q2 2017 | $640,000 | +20.8% | 3,711 | +6.9% | 0.02% | +14.3% |
Q1 2017 | $530,000 | +12.1% | 3,471 | +8.1% | 0.01% | +7.7% |
Q4 2016 | $473,000 | +25.1% | 3,212 | +7.5% | 0.01% | +18.2% |
Q3 2016 | $378,000 | +18.5% | 2,989 | +5.7% | 0.01% | +22.2% |
Q2 2016 | $319,000 | +19.0% | 2,829 | +9.7% | 0.01% | +12.5% |
Q1 2016 | $268,000 | +2.7% | 2,579 | +11.3% | 0.01% | 0.0% |
Q4 2015 | $261,000 | +13.5% | 2,317 | +10.4% | 0.01% | 0.0% |
Q3 2015 | $230,000 | +25.7% | 2,099 | +9.4% | 0.01% | +33.3% |
Q2 2015 | $183,000 | +7.6% | 1,918 | +4.9% | 0.01% | +20.0% |
Q1 2015 | $170,000 | -96.1% | 1,828 | -96.6% | 0.01% | -83.9% |
Q4 2014 | $4,377,000 | +27.8% | 53,449 | +0.1% | 0.03% | +14.8% |
Q3 2014 | $3,426,000 | +5.5% | 53,387 | -0.0% | 0.03% | +8.0% |
Q2 2014 | $3,248,000 | +1.7% | 53,412 | +0.1% | 0.02% | -3.8% |
Q1 2014 | $3,195,000 | -6.8% | 53,350 | -0.8% | 0.03% | -7.1% |
Q4 2013 | $3,427,000 | -16.9% | 53,796 | -11.4% | 0.03% | -40.4% |
Q3 2013 | $4,125,000 | +3122.7% | 60,717 | +3314.9% | 0.05% | +4600.0% |
Q2 2013 | $128,000 | – | 1,778 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KETTLE HILL CAPITAL MANAGEMENT, LLC | 102,189 | $15,390,000 | 3.64% |
NUANCE INVESTMENTS, LLC | 1,026,829 | $154,640,000 | 3.44% |
Nitorum Capital, L.P. | 252,826 | $38,076,000 | 3.31% |
Tamarack Advisers, LP | 15,000 | $2,259,000 | 1.33% |
KIRR MARBACH & CO LLC /IN/ | 21,811 | $3,285,000 | 1.11% |
Mesirow Institutional Investment Management, Inc. | 46,340 | $6,979,000 | 1.01% |
PFM Health Sciences, LP | 160,250 | $24,134,000 | 0.87% |
SEGALL BRYANT & HAMILL, LLC | 379,682 | $57,180,000 | 0.68% |
KENNEDY CAPITAL MANAGEMENT LLC | 145,845 | $21,964,000 | 0.65% |
River Road Asset Management, LLC | 285,630 | $43,016,000 | 0.64% |